{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:50:30Z","timestamp":1794473430546,"version":"4.9.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"33","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To assess the effects of 1- or \u22653-month dual antiplatelet therapy (DAPT) in high bleeding risk (HBR) patients who received biodegradable-polymer sirolimus-eluting stents for complex percutaneous coronary intervention (PCI) and\/or acute coronary syndrome (ACS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In the MASTER DAPT trial, 3383 patients underwent non-complex (abbreviated DAPT, n\u2009=\u20091707; standard DAPT, n\u2009=\u20091676) and 1196 complex (abbreviated DAPT, n\u2009=\u2009588; standard DAPT, n\u2009=\u2009608) PCI. Co-primary outcomes at 335 days were net adverse clinical events [NACE; composite of all-cause death, myocardial infarction, stroke, and bleeding academic research consortium (BARC) 3 or 5 bleeding events]; major adverse cardiac or cerebral events (MACCE; all-cause death, myocardial infarction, and stroke); and Types 2, 3, or 5 BARC bleeding. Net adverse clinical events and MACCE did not differ with abbreviated vs. standard DAPT among patients with complex [hazard ratio (HR): 1.03, 95% confidence interval (CI): 0.69\u20131.52, and HR: 1.24, 95% CI: 0.79\u20131.92, respectively] and non-complex PCI (HR: 0.90, 95% CI: 0.71\u20131.15, and HR: 0.91, 95% CI: 0.69\u20131.21; Pinteraction\u2009=\u20090.60 and 0.26, respectively). BARC 2, 3, or 5 was reduced with abbreviated DAPT in patients with and without complex PCI (HR: 0.64; 95% CI: 0.42\u20130.98, and HR: 0.70; 95% CI: 0.55\u20130.89; Pinteraction\u2009=\u20090.72). Among the 2816 patients with complex PCI and\/or ACS, NACE and MACCE did not differ and BARC 2, 3, or 5 was lower with abbreviated DAPT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In HBR patients free from recurrent ischaemic events at 1 month, DAPT discontinuation was associated with similar NACE and MACCE and lower bleeding rates compared with standard DAPT, regardless of PCI or patient complexity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration<\/jats:title>\n                    <jats:p>This trial is registered with ClinicalTrials.gov, number NCT03023020, and is closed to new participants, with follow-up completed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehac284","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T19:38:25Z","timestamp":1652816305000},"page":"3100-3114","source":"Crossref","is-referenced-by-count":79,"title":["Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4353-7110","authenticated-orcid":false,"given":"Marco","family":"Valgimigli","sequence":"first","affiliation":[{"name":"Cardiocentro Institute, Ente Ospedaliero Cantonale, Universit\u00e0 della Svizzera Italiana (USI) , CH-6900 Lugano , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter C","family":"Smits","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maasstad Hospital , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Frigoli","sequence":"additional","affiliation":[{"name":"CTU Bern, University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4162-1482","authenticated-orcid":false,"given":"Dario","family":"Bongiovanni","sequence":"additional","affiliation":[{"name":"Cardiocentro Institute, Ente Ospedaliero Cantonale, Universit\u00e0 della Svizzera Italiana (USI) , CH-6900 Lugano , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tijssen","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Center , Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hovasse","sequence":"additional","affiliation":[{"name":"Ramsay G\u00e9n\u00e9rale de Sant\u00e9, ICPS, H\u00f4pital Jacques Cartier , Massy , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al","family":"Mafragi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zorgsaam Hospital , Terneuzen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem Theodoor","family":"Ruifrok","sequence":"additional","affiliation":[{"name":"Treant Zorggroep , Emmen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitar","family":"Karageorgiev","sequence":"additional","affiliation":[{"name":"BAL Sveta Karidad , Plovdiv , Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Aminian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier Universitaire de Charleroi , Charleroi , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Garducci","sequence":"additional","affiliation":[{"name":"Unita\u2019 Operativa Complessa di Cardiologia, ASST Di Vimercate (MB) , Vimercate , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Merkely","sequence":"additional","affiliation":[{"name":"Heart and Vascular Center, Semmelweis University , Budapest , Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Routledge","sequence":"additional","affiliation":[{"name":"Worcestershire Royal Hospital , Worcester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital , Kitakyushu , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e8 Francisco","family":"Diaz Fernandez","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario Juan Ram\u00f3n Jim\u00e9nez , Huelva , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cuisset","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Marseille, Centre Hospitalier Universitaire La Timone, Service de Cardiologie , Marseille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazila Tun","family":"Nesa Malik","sequence":"additional","affiliation":[{"name":"National Heart Foundation Hospital and Research Institute , Dhaka , Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majdi","family":"Halabi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziv Medical Center , Safed , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Belle","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital of Annecy , Annecy , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehangir","family":"Din","sequence":"additional","affiliation":[{"name":"Royal Bournemouth Hospital , East Bournemouth , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2170-8983","authenticated-orcid":false,"given":"Farzin","family":"Beygui","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, Centre Hospitalier Universitaire (CHU) de Caen Normandie , Caen , France"},{"name":"\u00c9lectrophysiologie et imagerie des l\u00e9sions d'isch\u00e9mie-reperfusion myocardique, Normandie University, UNICAEN , Caen , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Abhyankar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shree B. D. Mehta Mahavir Heart Institute , Surat , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Reczuch","sequence":"additional","affiliation":[{"name":"Institute of Heart Diseases, Wroclaw Medical University , Wroc\u0142aw , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pedrazzini","sequence":"additional","affiliation":[{"name":"Cardiocentro Institute, Ente Ospedaliero Cantonale, Universit\u00e0 della Svizzera Italiana (USI) , CH-6900 Lugano , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dik","family":"Heg","sequence":"additional","affiliation":[{"name":"CTU Bern, University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Vranckx","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Critical Care Medicine, Hartcentrum Hasselt, Jessa Ziekenhuis Hasselt, Faculty of Medicine and Life Sciences, University of Hasselt , Hasselt , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MASTER DAPT Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"2022083123581794700_ehac284-B1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacc.2018.11.048","article-title":"Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting","volume":"73","author":"Costa","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022083123581794700_ehac284-B2","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2016.07.760","article-title":"Efficacy and safety of dual antiplatelet therapy after complex PCI","volume":"68","author":"Giustino","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2022083123581794700_ehac284-B3","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/ehjacc\/zuab090","article-title":"Ischaemic and bleeding risk in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: is it time to REACT?","volume":"10","author":"Valgimigli","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2022083123581794700_ehac284-B4","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/eurheartj\/ehz453","article-title":"Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial","volume":"40","author":"Serruys","year":"2019","journal-title":"Eur Heart J"},{"key":"2022083123581794700_ehac284-B5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ejcts\/ezx333","article-title":"European Society of Cardiology (ESC) focused update on dual antiplatelet therapy in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"53","author":"Jeppsson","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"2022083123581794700_ehac284-B6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"2022083123581794700_ehac284-B7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2022083123581794700_ehac284-B8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ahj.2018.10.009","article-title":"Design and rationale of the management of high bleeding risk patients post bioresorbable polymer coated stent implantation with an abbreviated versus standard DAPT regimen (MASTER DAPT) study","volume":"209","author":"Frigoli","year":"2019","journal-title":"Am Heart J"},{"key":"2022083123581794700_ehac284-B9","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"MASTER DAPT investigators. Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N Engl J Med"},{"key":"2022083123581794700_ehac284-B10","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"PRECISE-DAPT Study Investigators. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"key":"2022083123581794700_ehac284-B11","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jacc.2020.03.011","article-title":"Ticagrelor with or without aspirin after complex PCI","volume":"75","author":"Dangas","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022083123581794700_ehac284-B12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2022083123581794700_ehac284-B13","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCULATIONAHA.121.056680","article-title":"MASTER DAPT investigators abbreviated antiplatelet therapy in patients at high bleeding risk with or without oral anticoagulant therapy after coronary stenting: an open-label, randomized, controlled trial","volume":"144","author":"Smits","year":"2021","journal-title":"Circulation"},{"key":"2022083123581794700_ehac284-B14","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"DAPT study investigators. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"2022083123581794700_ehac284-B15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.5603\/CJ.a2021.0101","article-title":"P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: a post-hoc analysis of SMART-CHOICE randomized clinical trial","volume":"28","author":"Roh","year":"2021","journal-title":"Cardiol J"},{"key":"2022083123581794700_ehac284-B16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/ehjacc\/zuab077","article-title":"Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trial","volume":"10","author":"Coughlan","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2022083123581794700_ehac284-B17","doi-asserted-by":"crossref","first-page":"e010384","DOI":"10.1161\/CIRCINTERVENTIONS.120.010384","article-title":"Very short dual antiplatelet therapy after drug-eluting stent implantation in patients who underwent complex percutaneous coronary intervention: insight from the STOPDAPT-2 trial","volume":"14","author":"Yamamoto","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"2022083123581794700_ehac284-B18","doi-asserted-by":"crossref","first-page":"n1332","DOI":"10.1136\/bmj.n1332","article-title":"P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials","volume":"373","author":"Valgimigli","year":"2021","journal-title":"BMJ"},{"key":"2022083123581794700_ehac284-B19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jcin.2020.11.046","article-title":"Ticagrelor monotherapy versus dual-antiplatelet therapy after PCI: an individual patient-level meta-analysis","volume":"14","author":"Valgimigli","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2022083123581794700_ehac284-B20","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.jacc.2019.08.1038","article-title":"Ticagrelor alone versus dual antiplatelet therapy from 1 month after drug-eluting coronary stenting","volume":"74","author":"Franzone","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022083123581794700_ehac284-B21","first-page":"804","article-title":"Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRACER) randomized trial","volume":"38","author":"Valgimigli","year":"2017","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehac284\/44161226\/ehac284.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/33\/3100\/45585801\/ehac284.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/33\/3100\/45585801\/ehac284.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T19:58:56Z","timestamp":1661975936000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/33\/3100\/6587125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":21,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2022,6,22]]},"published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac284","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,6,22]]}}}